| 2021-10-07 | ASELAGE STEVE | Director | Sale+OE | 60,000 | $26.25 | $1,574,760.00 | -12.7% | → |
| 2021-10-04 | Heerma Peter | Chief Commercial Officer | Sell | 3,058 | $24.77 | $75,746.05 | -4.8% | → |
| 2021-08-17 | Heerma Peter | Chief Commercial Officer | Sell | 1,407 | $17.12 | $24,086.01 | -2.2% | → |
| 2021-08-17 | Dube Eric M | Chief Executive Officer | Sell | 7,836 | $17.12 | $134,142.13 | -4.8% | → |
| 2021-08-17 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,407 | $17.12 | $24,085.03 | -2.9% | → |
| 2021-08-17 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 1,407 | $17.12 | $24,085.45 | -3.8% | → |
| 2021-08-17 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 1,407 | $17.12 | $24,086.01 | -3.6% | → |
| 2021-08-17 | Clague Laura | Chief Financial Officer | Sell | 1,407 | $17.12 | $24,085.31 | -4.3% | → |
| 2021-07-28 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,250 | $13.81 | $17,262.50 | -2.7% | → |
| 2021-06-02 | Dube Eric M | Chief Executive Officer | Sell | 9,562 | $14.62 | $139,796.98 | -3.1% | → |
| 2021-05-12 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 3,125 | $19.30 | $60,312.34 | -4.6% | → |
| 2021-05-12 | Rosenberg Noah L. | Chief Medical Officer | Sell | 750 | $19.30 | $14,475.00 | -0.8% | → |
| 2021-05-12 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 3,250 | $19.30 | $62,725.00 | -4.4% | → |
| 2021-05-12 | Clague Laura | Chief Financial Officer | Sell | 4,000 | $19.30 | $77,200.00 | -6.4% | → |
| 2021-05-11 | ASELAGE STEVE | Director | Sell | 2,146 | $19.58 | $42,022.97 | -1.1% | → |
| 2021-04-16 | ASELAGE STEVE | Director | Sale+OE | 10,000 | $26.23 | $262,300.00 | -5.0% | → |
| 2021-03-17 | ASELAGE STEVE | Director | Sale+OE | 17,727 | $27.44 | $486,456.12 | -4.4% | → |
| 2021-02-18 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 2,500 | $28.01 | $70,025.00 | -3.4% | → |
| 2021-02-08 | Rosenberg Noah L. | Chief Medical Officer | Sell | 2,250 | $31.50 | $70,863.75 | -2.3% | → |
| 2021-02-08 | Heerma Peter | Chief Commercial Officer | Sell | 2,250 | $31.50 | $70,863.75 | -1.8% | → |
| 2021-02-08 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 4,500 | $31.50 | $141,727.50 | -5.5% | → |
| 2021-02-08 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 4,500 | $31.50 | $141,727.50 | -5.5% | → |
| 2021-02-08 | Clague Laura | Chief Financial Officer | Sell | 4,500 | $31.50 | $141,727.50 | -6.3% | → |
| 2021-02-08 | Dube Eric M | Chief Executive Officer | Sell | 9,626 | $31.50 | $303,170.87 | -2.9% | → |
| 2021-02-03 | Clague Laura | Chief Financial Officer | Sell | 3,625 | $28.91 | $104,798.75 | -5.2% | → |
| 2021-02-03 | Rosenberg Noah L. | Chief Medical Officer | Sell | 1,813 | $28.91 | $52,413.83 | -2.0% | → |
| 2021-02-03 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 3,625 | $28.91 | $104,798.75 | -4.6% | → |
| 2021-02-03 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 3,175 | $28.91 | $91,789.25 | -4.0% | → |
| 2021-02-03 | Dube Eric M | Chief Executive Officer | Sell | 2,406 | $28.91 | $69,557.46 | -1.6% | → |
| 2021-02-03 | Heerma Peter | Chief Commercial Officer | Sell | 1,126 | $29.83 | $33,588.58 | -1.0% | → |
| 2021-02-02 | ASELAGE STEVE | Director | Sale+OE | 25,000 | $30.75 | $768,750.00 | -11.3% | → |